The Food and Drug Administration recently issued its final guidance on the appearance of generic pharmaceuticals, recommending that drugs made by generic manufacturers closely mimic the physical attributes, including the size, shape and color, of the drugs that they reference.
To help independent pharmacy owners better understand the fast-growing, uber-complex specialty pharmacy business, the National Community Pharmacists Association last month hosted a day-long forum, “Exploring the intersection of specialty medications, community pharmacy and patient care.”
Rite Aid is back — and in a very big way. After years of toiling in the shadows of its fast-growing and better-capitalized rivals, the company has regained its footing and market momentum with a renewed vitality and a sharply defined focus on its mission as a community-driven health-and-wellness retailer.
On the occasion of the 2015 White House Conference on Aging, which marks the sixth such event since the first in 1961, National Association of Chain Drug Stores president and CEO Steve Anderson joined the dialogue by issuing a statement.
One of the biggest challenges to patient adherence is that patients can’t take their medications if they can’t afford them. In December, McKesson developed a solution for its customers to help their patients stay adherent with their prescriptions.
Phil Hagerman, CEO and Chairman of Diplomat Pharmacy, Inc., joined attendees as a special guest speaker for a “Specialty Lunch and Learn,” at McKesson’s ideaShare 2015. “Specialty is the new pharmacy,” Hagerman said.